Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2025 | 1 | -$21.00 | -$21.00 | -$21.00 |
| Q3 2025 | 1 | -$12.50 | -$12.50 | -$12.50 |
| Q4 2025 | 1 | -$13.00 | -$13.00 | -$13.00 |
Genprex, Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-5 earnings per share for the quarter, topping analysts' consensus estimates of $-12.5 by $7.5. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Genprex, Inc. has generated $-267 earnings per share over the last year ($-266.9535 diluted earnings per share) and currently has a price-to-earnings ratio of -0.15. Genprex, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 3rd, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$12.50 | -$5.00 | 7.5 | $0 | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$8.50 | N/A | $0 | $0 |
| 05/12/2025 | Q1 2025 | -$0.82 | -$13.00 | -12.18 | $0 | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$21.00 | N/A | $0 | $0 |
| 11/13/2024 | Q3 2024 | -$1.13 | -$61.50 | -60.37 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$2.30 | -$150.00 | -147.7 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$2.54 | -$184.50 | -181.96 | N/A | $0 |
| 04/01/2024 | Q4 2023 | N/A | -$199.50 | N/A | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$0.11 | -$268.00 | -267.89 | N/A | $0 |
| 08/21/2023 | Q2 2023 | -$4.80 | -$307.00 | -302.2 | N/A | $0 |
| 05/22/2023 | Q1 2023 | -$4.80 | -$372.00 | -367.2 | N/A | $0 |
| 03/31/2023 | Q4 2022 | -$5.20 | -$266.50 | -261.3 | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.12 | -$252.50 | -252.38 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$4.00 | -$241.00 | -237 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$3.60 | -$239.00 | -235.4 | N/A | $0 |
| 03/30/2022 | Q4 2021 | -$0.09 | -$237.50 | -237.41 | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$144.50 | N/A | N/A | $0 |
| 08/13/2021 | Q2 2021 | -$0.13 | -$168.50 | -168.37 | N/A | $0 |
| 05/17/2021 | Q1 2021 | -$0.12 | -$285.00 | -284.88 | N/A | $0 |
| 03/26/2021 | Q4 2020 | -$0.28 | -$264.00 | -263.72 | N/A | $0 |
Genprex, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 3rd, 2025 based offlast year's report dates.
In the previous quarter, Genprex, Inc. (:GNPX) reported $-5 earnings per share (EPS) to beat the analysts' consensus estimate of $-12.5 by $7.5.
The conference call for Genprex, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Genprex, Inc.'s latest earnings report can be read online.
Genprex, Inc. (:GNPX) has a recorded net income of $-21,111,163.Genprex, Inc. has generated $-266.9535 earnings per share over the last four quarters.
Genprex, Inc. (:GNPX) has a price-to-earnings ratio of -0.15 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED